Pulmonary Arterial Hypertension in Pediatric Patients with Hematopoietic Stem Cell Transplant–Associated Thrombotic Microangiopathy  Sonata Jodele, Russel.

Slides:



Advertisements
Similar presentations
Evidence of B Cell Immune Responses to Acute Lymphoblastic Leukemia in Murine Allogeneic Hematopoietic Stem Cell Transplantation Recipients Treated with.
Advertisements

Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation 
Trend, Risk Factors and Outcome of Thrombotic Microangiopathy in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Multi-Institutional Review 
BK Viremia Precedes Hemorrhagic Cystitis in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation  Benjamin L. Laskin, Michelle Denburg,
Michael A. Pulsipher, Christina Peters, Ching-Hon Pui 
How to Treat MDS without Stem Cell Transplantation
The Effect of Statin Use at the Time of Autologous Transplant on Response and Survival in Multiple Myeloma  Mehdi Hamadani, Erinn Hade, Don M. Benson,
Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation  Javier.
Kidney and Bladder Outcomes in Children with Hemorrhagic Cystitis and BK Virus Infection after Allogeneic Hematopoietic Stem Cell Transplantation  Benjamin.
Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation 
Intravenous Busulfan-Cyclophosphamide as a Preparative Regimen Before Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Acute.
Reduced-Intensity Conditioning Hematopoietic Cell Transplantation Is an Effective Treatment for Patients with SLAM-Associated Protein Deficiency/X-linked.
Peter Hurley, Suma Konety, Qing Cao, Daniel Weisdorf, Anne Blaes 
Allogeneic Stem Cell Transplantation for Relapsed or Refractory Lymphoma after Conditioning with BEAM/Fludarabine/TBI  Alix O’Meara, Jörg Halter, Dominik.
David Myerson, Gideon Steinbach, Ted A. Gooley, Howard M. Shulman 
Progressive Systemic Sclerosis
Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA) 
Hematopoietic Stem Cell Transplantation after Reduced Intensity Conditioning in Acute Myelogenous Leukemia Patients Older Than 40 Years  Cynthia Huisman,
Sabina Kersting, Leo F. Verdonck 
Assessment of the Hematopoietic Cell Transplantation Comorbidity Index in Non- Hodgkin Lymphoma Patients Receiving Reduced-Intensity Allogeneic Hematopoietic.
Pulmonary Hypertensive Vasculopathy Following Tandem Autologous Transplantation in Pediatric Patients with Central Nervous System Tumors  Tal Schechter,
Vascular Endothelial Growth Factor and Activin-A Serum Levels Following Allogeneic Hematopoietic Stem Cell Transplantation  David Nachbaur, Petra Schumacher,
Blood, and Not Urine, BK Viral Load Predicts Renal Outcome in Children with Hemorrhagic Cystitis following Hematopoietic Stem Cell Transplantation  Hilary.
Gregory Wallace, DO, Sonata Jodele, MD, Kasiani C
Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer  Brigitta Omazic, Mats Remberger, Lisbeth Barkholt, Gunnar.
A Genetic Modifier of the Gut Microbiome Influences the Risk of Graft-versus-Host Disease and Bacteremia After Hematopoietic Stem Cell Transplantation 
Carbon Monoxide Diffusion Capacity: How Low Can You Go for Hematopoietic Cell Transplantation Eligibility?  Jason W. Chien, Keith M. Sullivan  Biology.
Clinical Utility of Computed Tomography and Magnetic Resonance Imaging for Diagnosis of Posterior Reversible Encephalopathy Syndrome after Stem Cell.
Chronic Kidney Disease in Long-Term Survivors after Allogeneic Hematopoietic Stem Cell Transplantation: Retrospective Analysis at a Single Institute 
Early Soluble ST2 Elevation Predicts Future Left Ventricular Systolic Dysfunction after Stem Cell Transplant  Christopher E. Dandoy, MD, MSc, Thomas D.
Pulmonary Hypertension Associated with Bronchiolitis Obliterans after Stem Cell Transplant  Christopher E. Dandoy, MD, MSc, Abigail Pate, Mikako Warren,
High-Dose Weekly AmBisome Antifungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Pharmacokinetic Study  Parinda.
Favorable Outcome for Infant Acute Lymphoblastic Leukemia after Hematopoietic Stem Cell Transplantation  David A. Jacobsohn, Brad Hewlett, Elaine Morgan,
Pulmonary Hypertension after Hematopoietic Stem Cell Transplantation
Christopher C. Dvorak, Rajni Agarwal, Gary V. Dahl, John J
New Light Chain Amyloid Response Criteria Help Risk Stratification of Patients by Day 100 after Autologous Hematopoietic Cell Transplantation  Anita D'Souza,
A Process to Facilitate Decision Making in Pediatric Stem Cell Transplantation: The Individualized Care Planning and Coordination Model  Justin N. Baker,
Genotype-Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation  Ashley Teusink,
Gregory Wallace, Sonata Jodele, Jonathan Howell, Kasiani C
Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after.
Seth Joshua Rotz, Nathan Luebbering, Bradley P. Dixon, Christopher E
Alternate-Day Micafungin Antifungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Pharmacokinetic Study  Parinda.
Donor Selection in T Cell–Replete Haploidentical Hematopoietic Stem Cell Transplantation: Knowns, Unknowns, and Controversies  Stefan O. Ciurea, Richard.
Therapeutic Plasma Exchange does not Improve Renal Function in Hematopoietic Stem Cell Transplantation–Associated Thrombotic Microangiopathy: An Institutional.
Endothelial Injury, Neutrophil Extracellular Traps, and Complement Activation in Thrombotic Microangiopathy and GVHD  Nicholas J. Gloude, Sonata Jodele,
Paul A. Hoffmeister, Sangeeta R. Hingorani, Barry E. Storer, K
Children after Allogeneic Hematopoietic Cell Transplantation Can Develop BK Virus Nephropathy: Pilot Data Using Urinary Polyomavirus-Haufen Testing  Benjamin.
Sabina Kersting, Ronald J. Hené, Hein A. Koomans, Leo F. Verdonck 
Early Results of Phase II Study Using OMS721 in Patients with Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HCT-TMA)  Samer.
Histologic Features of Intestinal Thrombotic Microangiopathy in Patients with High Risk TMA after HSCT  Javier El-Bietar, MD, Mikako Warren, MD, Christopher.
Sonata Jodele, Kejian Zhang, Christopher E. Dandoy, Kasiani C
Volume 63, Issue 1, Pages (January 2003)
The Kidney Effects of Hematopoietic Stem Cell Transplantation
Pauline Damien, David S. Allan 
What is quality in a transplant program?
Participation in Clinical Research: Perspectives of Adult Patients and Parents of Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation 
Allogeneic Hematopoietic Stem Cell Transplantation in FLT3-ITD–Positive Acute Myelogenous Leukemia: The Role for FLT3 Tyrosine Kinase Inhibitors Post-
Improving the Informed Consent Process in Hematopoietic Cell Transplantation: Patient, Caregiver, and Provider Perspectives  Minakshi Raj, Sung Won Choi,
Blood and Marrow Transplant Handbook
Young Female Donors Do Not Increase the Risk of Graft-versus-Host Disease or Impact Overall Outcomes in Pediatric HLA-Matched Sibling Hematopoietic Stem.
Low Serum Levels of Total Rabbit-IgG Is Associated with Acute Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation:
Alveolar Hemorrhage and Acute Graft-versus-Host Disease
Mammen Chandy  Biology of Blood and Marrow Transplantation 
Reduced Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation: Current Perspectives  Brenda M. Sandmaier, Stephen Mackinnon, Richard.
Impact of Pretransplantation Indices in Hematopoietic Stem Cell Transplantation: Knowledge of Center-Specific Outcome Data Is Pivotal before Making Index-Based.
IL-8 Levels Early after Bone Marrow Transplant are Associated with Later Complications of Stem Cell Transplantation  Nikhil Dole, Nathan Luebbering, Nicholas.
William Berquist, MD  Gastrointestinal Endoscopy 
Eculizumab Therapy in Children with Severe Hematopoietic Stem Cell Transplantation– Associated Thrombotic Microangiopathy  Sonata Jodele, Tsuyoshi Fukuda,
Mary Eapen  Biology of Blood and Marrow Transplantation 
In Memoriam: E. Donnall Thomas
Presentation transcript:

Pulmonary Arterial Hypertension in Pediatric Patients with Hematopoietic Stem Cell Transplant–Associated Thrombotic Microangiopathy  Sonata Jodele, Russel Hirsch, Benjamin Laskin, Stella Davies, David Witte, Ranjit Chima  Biology of Blood and Marrow Transplantation  Volume 19, Issue 2, Pages 202-207 (February 2013) DOI: 10.1016/j.bbmt.2012.08.022 Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 1 Lung histology from autopsy specimens showing histopathologic changes of transplantation-associated thrombotic microangiopathy (TA-TMA) and pulmonary arterial hypertension (PAH). (A), Lung histology from patient 1 (1a, b, c), patient 3 (2a, b, c), and patient 4 (3a, b, c) demonstrated severe vascular disease involving pulmonary arterioles. All 3 autopsies demonstrated different stages of severe vascular injury present in the same sample ranging from acute microangiopathic vascular injury (1a, 2a, 3a) to subacute (1b, 2b, 3b), and finally severe obliterative changes consistent with histological evidence of PAH (1c, 2c, 3c) (H&E, ×40). Black arrowheads show acute and subacute signs of TMA with endothelial cells “floating” in the vascular lumen after complete separation from the basement membrane. Transparent arrowheads indicate red cell fragments extravagated into surrounding tissues. Other vessels show thickening of all 3 layers of the vascular wall, with up to 95% occlusion of the arteriolar lumens in all lung pathology samples (solid double headed arrows, 1c, 2c, 3c). Some areas have intra-arteriolar fibrin microthrombi (star) with focal areas of organization suggestive of chronic and progressive endothelial injury. 1b, 2b, and 3b depict subacute vascular injury with separated endothelium (black arrowheads) and initial stages of proliferation of vascular wall (dotted double arrows). (B), Lung histology from patient 3 (H&E, ×40) illustrating different stages of vascular injury ranging from acute vascular lesions with separation of the endothelium (black arrowheads), lumen occluding fibrin and cell debris (dotted double headed arrow) with severe red cell fragmentation and extravasation into surrounding tissues (transparent arrowhead), to advanced proliferation of vascular wall (solid double headed arrow) with fibrin microthrombi with focal evidence of organization and near obliteration of vascular lumen (star). Biology of Blood and Marrow Transplantation 2013 19, 202-207DOI: (10.1016/j.bbmt.2012.08.022) Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 2 Screening and follow-up algorithm for pulmonary arterial hypertension (PAH) in pediatric patients who underwent hematopoietic stem cell transplant (HSCT). TA-TMA indicates transplantation-associated thrombotic microangiopathy. Biology of Blood and Marrow Transplantation 2013 19, 202-207DOI: (10.1016/j.bbmt.2012.08.022) Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions